Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
14.15
-0.21 (-1.46%)
At close: Aug 1, 2025, 4:00 PM
13.87
-0.28 (-1.98%)
After-hours: Aug 1, 2025, 7:56 PM EDT

Ligand Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22
516649--
Enterprise Value
239330--
Last Close Price
14.1517.74--
Debt / Equity Ratio
0.030.010.050.54
Quick Ratio
30.4234.8216.7518.74
Current Ratio
31.0135.3417.1418.80
Return on Equity (ROE)
-33.14%-35.09%-43.36%-
Return on Assets (ROA)
-22.88%-22.07%-24.18%-
Return on Capital (ROIC)
-23.71%-22.86%-25.52%-
Buyback Yield / Dilution
-1632.08%-1277.25%-93.74%-
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q